Poster | 6th Internet World Congress for Biomedical Sciences |
Karen K. Szumlinski(1)
(1)Albany Medical College - Albany. United States
[Neuroscience] |
[Pharmacology] |
[Psychiatry] |
Figure 1. Structure of 18-methoxycoronaridine (18-MC). |
Figure 2. Effects of pretreatment with 18-MC or VEH on the dose-response relationship for locomotion in rats acutely treated with MOR. *P<0.05 vs. VEH (Duncanīs post-hoc tests) |
Figure 5. Total locomotor response of animals treated daily with either SAL or COC. + P<0.05 vs. injection 1 (Duncanīs post-hoc tests) |
Figure 6. Composite of the effects of 18-MC or VEH pretreatment on the dose-response curve for total locomotion induced by COC in animals treated chronically with either SAL (left) or COC (right). |
[Neuroscience] |
[Pharmacology] |
[Psychiatry] |